Lallement_2000_Ann.Pharm.Fr_58_18

Reference

Title : [Interest in an glutamate antagonistic compound for the treatment of organophosphate poisoning] - Lallement_2000_Ann.Pharm.Fr_58_18
Author(s) : Lallement G
Ref : Ann Pharm Fr , 58 :18 , 2000
Abstract :

Classical emergency treatment of organophosphate poisoning includes the combined administration of a cholinesterase reactivator (an oxime), a muscarinic cholinergic receptor antagonist (atropine) and a benzodiazepine anticonvulsant (diazepam). In subjects taking pyridostigmine and trained to autoadminister at least one autoinjector at the first signs of poisoning, classical emergency treatment ensures survival but only an antiglutamatergic compound like gacyclidine appears to be able to ensure optimal management of nerve agent poisoning in terms of rapid normalization of EEG activity, clinical recovery and total neuroprotection. All of this reinforces the therapeutical value of gacyclidine, which is in the process of approval for human use in France for treatment of head injury, as a central nervous system protective agent for the treatment of OP poisoning.

PubMedSearch : Lallement_2000_Ann.Pharm.Fr_58_18
PubMedID: 10669807

Related information

Citations formats

Lallement G (2000)
[Interest in an glutamate antagonistic compound for the treatment of organophosphate poisoning]
Ann Pharm Fr 58 :18

Lallement G (2000)
Ann Pharm Fr 58 :18